An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

sNN0029

ICV infusion

Trial Locations (1)

University Hospital Leuven, Department of Neurology, Leuven